After a year of restructuring, difficult sales, and political turmoil, the pharma industry is entering 2026 with cautious optimism. With more than 400 launches planned this year, things are looking up.
To take advantage of this opportunity, medical leaders will need to ensure field medical teams are working as efficiently, cooperatively, and strategically as possible. There will be more stakeholders, busier KOLs, and a flavor of AI in everything they do. Frequent and ongoing skill-building is a must.
Fortunately, medical affairs professionals are natural learners. Filled with curiosity and equipped with specialized degrees, they are a prime audience for learning and developing new skills. In this report, we describe six waves rocking the pharma industry and how learning and development leaders who ride them can steer their crews to success.